Cargando…

The GSTT1 genotype is associated with p53 mutation status of breast cancer tumours

Detalles Bibliográficos
Autores principales:	Gudmundsdóttir, K, Tryggvadóttir, L, Eyfjörd, JE
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2000
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300860/ http://dx.doi.org/10.1186/bcr162

Ejemplares similares

CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status
por: Gudmundsdottir, K, et al.
Publicado: (2003)

P53 mutations in breast and ovarian carcinomas from BRCA1 and 2 mutation carriers and noncarriers
por: Sensi, E, et al.
Publicado: (2000)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Germline TP53 mutations in Finnish breast cancer patients
por: Rapakko, K, et al.
Publicado: (2000)

Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
por: Alsner, J, et al.
Publicado: (2000)

TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material.
por: Gretarsdottir, S., et al.
Publicado: (1996)

BRCA2 interacting proteins
por: Vidarsson, H, et al.
Publicado: (2000)

Targeting p53 by small molecule p53 activators in multiple myeloma
por: Saha, Manujendra N, et al.
Publicado: (2012)

Germline BRCA2 and somatic P53 alterations in male breast cancer
por: Csokay, B, et al.
Publicado: (2000)

Overexpression of the autoantigen hnRNP-A2 (RA33), the tumour suppressor p53 and activated MAP-Kinase p38 in inflamed synovial tissue
por: Hayer, S, et al.
Publicado: (2002)

Breast cancer in young women: prevalence of LOH at p53, BRCA1 and BRCA2
por: Johnson, SM, et al.
Publicado: (2000)

The influence of GSTT/GSTM null genotypes in scarring
por: Ilieş, Roxana Flavia, et al.
Publicado: (2019)

TP53 and p16INK4A mutations in adult-T cell leukemia/lymphoma (ATL) in Bahia (Brazil)
por: Magalhães, Marcelo, et al.
Publicado: (2011)

IKKbeta and p53 as therapeutic targets for arthritis
por: Tak, PP
Publicado: (2001)

Selenium and genotypes as marker of risk in BRCA1 mutation carriers
por: Jaworska, K, et al.
Publicado: (2012)

Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in Trp53+/- mice
por: Blackburn, AC, et al.
Publicado: (2012)

Inherited and de novo germline TP53 mutations in adult-onset sarcoma
por: Thomas, David M, et al.
Publicado: (2012)

Inherited and de novo germline TP53 mutations in adult-onset sarcoma
por: Thomas, DM, et al.
Publicado: (2012)

PW01-019 – MEFV gene mutations in 53 periodic fever patients
por: Toplak, N, et al.
Publicado: (2013)

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer
por: Andersen, TI, et al.
Publicado: (2000)

Comparing ion torrent with pyrosequencing and Sanger sequencing for the detection of TP53 mutations in colorectal cancer
por: Doyle, Brendan, et al.
Publicado: (2014)

P01-008 – FMF genotype-phenotype correlations in Germany
por: Jeske, M, et al.
Publicado: (2013)

BRCA2 mutation carriers, reproductive factors and breast cancer risk
por: Tryggvadottir, Laufey, et al.
Publicado: (2003)

Comparative analysis of breast and colorectal tumours uncouples loss of DNA methylation in cancer from association with the nuclear periphery
por: Kerr, Elizabeth, et al.
Publicado: (2013)

Pathogenic germline TP53 mutations in adult sarcoma patients; implications for treatment and screening – description of an upcoming project
por: Mahendran, K, et al.
Publicado: (2012)

Oral contraceptive (OC) use and risk of breast cancer - reply
por: Tryggvadóttir, L, et al.
Publicado: (1997)

Embryonic lethality in the Brca1-1700T mouse model suggests inhibition of p53-dependent pathways
por: Hohenstein, P, et al.
Publicado: (2000)

Upregulation of p18Ink4c expression by HPV E6 via p53-miR-34a pathway
por: Wang, Xiaohong, et al.
Publicado: (2010)

Association of GSTM1 and GSTT1 Null Genotypes with Toluene Diisocyanate-Induced Asthma
por: Lee, Jong-Uk, et al.
Publicado: (2022)

Negative regulation of p53 expression is an essential, rate-limiting function of Jun in the control of cell cycle progression
por: Schreiber, M, et al.
Publicado: (2000)

Arsenite induces oxidative stress and caspase 3-mediated apoptosis in human neuroblastoma cells involving p53
por: Keim, A, et al.
Publicado: (2009)

Screening breast cancer patients for Norwegian ATM mutations
por: Laake, K, et al.
Publicado: (2000)

Absence of GSTT1 and polymorphisms in GSTP1 and TP53 are associated with the incidence of acne vulgaris
por: Ullah, Rehmat, et al.
Publicado: (2023)

Loss of MSH6 and PMS2 immunohistochemical staining in tumour tissue of two individuals with a germline PMS2 mutation
por: Edwards, E, et al.
Publicado: (2012)

The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

BRCA1 mutation in the Triple- Negative Breast Cancer Group
por: Maksimenko, Jelena, et al.
Publicado: (2012)

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
por: Phillips, KA, et al.
Publicado: (2012)

P03-012 - A P268S NOD2 mutation in one Blau patient
por: Pardeo, M, et al.
Publicado: (2013)

P03-005 - MEFV heterozygous mutations in PFAPA patients
por: Kozlova, A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8tl1t5tcrqca6cqpap5ma56kha